These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9088591)

  • 21. Dietary sodium and inhibition of neutral endopeptidase 24.11 in essential hypertension.
    Singer DR; Markandu ND; Buckley MG; Miller MA; Sagnella GA; MacGregor GA
    Hypertension; 1991 Dec; 18(6):798-804. PubMed ID: 1835959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of chronic neutral endopeptidase inhibition on cardiac hypertrophy after experimental myocardial infarction.
    Yoshida K; Yasujima M; Casley DJ; Johnston CI
    Jpn Circ J; 1998 Sep; 62(9):680-6. PubMed ID: 9766707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual inhibition of angiotensin converting enzyme and neutral endopeptidase produces effective blood pressure control in spontaneously hypertensive rats.
    Kostova E; Jovanoska E; Zafirov D; Jakovski K; Maleska V; Slaninka-Miceska M
    Bratisl Lek Listy; 2005; 106(12):407-11. PubMed ID: 16642666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of inhibition of endopeptidase 24.11 on responses to angiotensin II in human volunteers.
    Richards AM; Wittert GA; Espiner EA; Yandle TG; Ikram H; Frampton C
    Circ Res; 1992 Dec; 71(6):1501-7. PubMed ID: 1423942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemodynamic and neuroendocrine effects for candoxatril and frusemide in mild stable chronic heart failure.
    Westheim AS; Bostrøm P; Christensen CC; Parikka H; Rykke EO; Toivonen L
    J Am Coll Cardiol; 1999 Nov; 34(6):1794-801. PubMed ID: 10577572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potentiation of urinary atrial natriuretic peptide interferes with macula densa function.
    Haloui M; Messika-Zeitoun D; Louedec L; Philippe M; Michel JB
    Cardiovasc Res; 2001 Aug; 51(3):542-52. PubMed ID: 11476744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal and hormonal effects of chronic inhibition of neutral endopeptidase (EC 3.4.24.11) in normal man.
    O'Connell JE; Jardine AG; Davies DL; McQueen J; Connell JM
    Clin Sci (Lond); 1993 Jul; 85(1):19-26. PubMed ID: 8149689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natriuretic and renoprotective effect of chronic oral neutral endopeptidase inhibition in acute renal failure.
    Newaz M; Yousefipour Z; Oyekan A
    Ren Fail; 2010 Jan; 32(3):384-90. PubMed ID: 20370457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calcitonin gene-related peptide is not elevated in rat plasma by heart failure or by neutral endopeptidase inhibition.
    Helin K; Tikkanen I; Kiilavuori K; Näveri H; Fyhrquist F
    Life Sci; 1994; 55(6):471-7. PubMed ID: 8035665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Natriuretic and antialdosterone actions of chronic oral NEP inhibition during progressive congestive heart failure.
    Martin FL; Stevens TL; Cataliotti A; Schirger JA; Borgeson DD; Redfield MM; Luchner A; Burnett JC
    Kidney Int; 2005 May; 67(5):1723-30. PubMed ID: 15840018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natriuretic peptide system and endothelin in aneurysmal subarachnoid hemorrhage.
    Wijdicks EF; Schievink WI; Burnett JC
    J Neurosurg; 1997 Aug; 87(2):275-80. PubMed ID: 9254093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma brain natriuretic peptide and endopeptidase 24.11 inhibition in hypertension.
    Richards AM; Crozier IG; Espiner EA; Yandle TG; Nicholls MG
    Hypertension; 1993 Aug; 22(2):231-6. PubMed ID: 8340158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Candoxatril improves exercise capacity in patients with chronic heart failure receiving angiotensin converting enzyme inhibition.
    Newby DE; McDonagh T; Currie PF; Northridge DB; Boon NA; Dargie HJ
    Eur Heart J; 1998 Dec; 19(12):1808-13. PubMed ID: 9886723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical correlates of elevated plasma natriuretic peptides and Big endothelin-1 in a population of ambulatory patients with heart failure. A substudy of the Italian Network on Congestive Heart Failure (IN-CHF) registry. IN-CHF Investigators.
    Masson S; Gorini M; Salio M; Lucci D; Latini R; Maggioni AP
    Ital Heart J; 2000 Apr; 1(4):282-8. PubMed ID: 10824729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of digoxin on atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and cyclic 3', 5'-guanosine monophosphate (cGMP) in patients with chronic congestive heart failure].
    Kobusiak-Prokopowicz M; Swidnicka-Szuszkowska B; Mysiak A
    Pol Arch Med Wewn; 2001 Jun; 105(6):475-82. PubMed ID: 11865578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure.
    Clerico A; Iervasi G; Del Chicca MG; Emdin M; Maffei S; Nannipieri M; Sabatino L; Forini F; Manfredi C; Donato L
    J Endocrinol Invest; 1998 Mar; 21(3):170-9. PubMed ID: 9591213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regional plasma levels of cardiac peptides and their response to acute neutral endopeptidase inhibition in man.
    Lainchbury JG; Nicholls MG; Espiner EA; Ikram H; Yandle TG; Richards AM
    Clin Sci (Lond); 1998 Nov; 95(5):547-55. PubMed ID: 9791040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Responses of plasma concentrations of A type natriuretic peptide and B type natriuretic peptide to alacepril, an angiotensin-converting enzyme inhibitor, in patients with congestive heart failure.
    Yoshimura M; Yasue H; Tanaka H; Kikuta K; Sumida H; Kato H; Jougasaki M; Nakao K
    Br Heart J; 1994 Dec; 72(6):528-33. PubMed ID: 7857734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel neurohormonal modulators in cardiovascular disorders. The therapeutic potential of endopeptidase inhibitors.
    Kentsch M; Otter W
    Drugs R D; 1999 Apr; 1(4):331-8. PubMed ID: 10566056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. N-terminal pro-atrial natriuretic peptide (N-ANP) and N-terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction.
    Squire IB; O'Brien RJ; Demme B; Davies JE; Ng LL
    Clin Sci (Lond); 2004 Sep; 107(3):309-16. PubMed ID: 15182235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.